Assessing interventions and outcomes of a pharmaceutical care programme directed at asthma patients

Pharmaceutical Journal

Volumn 263, Issue 7063 SUPPL. 1, 1999, Pages

  Cordina, M ^a   McElnay, J C ^b   Hughes, C M ^b  

^a UNIVERSITY OF MALTA   (Malta)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4243321570     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Helper CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43.
2. Grainger-Rousseau TJ, McElnay JC. A model for community pharmacist involvement with general practitioners in the management of asthma patients. J Appl Ther 1996; 1:145-61.
3. De Tullio PI, Corson E. Effect of pharmacist counselling on ambulatory patients use of aerosolised bronchodilators. Am J Hosp Pharm 1987;44: 1802-6.
4. Stewart A, Greenfield S, Hays RD et al. Functional status and well-being of patients with chronic conditions, Results of Medical Outcomes Study. JAMA 1989; 262:907-13
5. Hyland ME, Finns S, Irvine SH. A scale for assessing the quality of life in adult asthma sufferers. J Psychom Res 1991; 35:99-110.